Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 604

1.

Associations Between Soluble LDLR and Lipoproteins in a Caucasian Cohort and The Effect of PCSK9 Loss-of-Function.

Mayne J, Ooi TC, Tepliakova L, Seebun D, Walker K, Mohottalage D, Ning Z, Abujrad H, Mbikay M, Wassef H, Chrétien M, Figeys D.

J Clin Endocrinol Metab. 2018 Jun 21. doi: 10.1210/jc.2018-00777. [Epub ahead of print]

PMID:
29982529
2.

[Retrospective study of 25 cases of pulmonary mucormycosis in acute leukaemia].

Caillot D, Legouge C, Lafon I, Ferrant E, Pagès PB, Plocque A, Estivalet L, Valot S, Dalle F, Abou Hanna H, Chretien ML.

Rev Mal Respir. 2018 Apr;35(4):452-464. doi: 10.1016/j.rmr.2017.11.009. Epub 2018 May 10. Review. French.

PMID:
29754839
3.

HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis.

Sevin M, Kubovcakova L, Pernet N, Causse S, Vitte F, Villeval JL, Lacout C, Cordonnier M, Rodrigues-Lima F, Chanteloup G, Mosca M, Chrétien ML, Bastie JN, Audia S, Sagot P, Ramla S, Martin L, Gleave M, Mezger V, Skoda R, Plo I, Garrido C, Girodon F, de Thonel A.

Nat Commun. 2018 Apr 12;9(1):1431. doi: 10.1038/s41467-018-03627-9.

4.

Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.

Rossi C, Chrétien ML, Casasnovas RO.

Target Oncol. 2018 Jun;13(3):287-308. doi: 10.1007/s11523-018-0558-1.

PMID:
29556925
5.

Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment.

Nakamura K, Kassem S, Cleynen A, Chrétien ML, Guillerey C, Putz EM, Bald T, Förster I, Vuckovic S, Hill GR, Masters SL, Chesi M, Bergsagel PL, Avet-Loiseau H, Martinet L, Smyth MJ.

Cancer Cell. 2018 Apr 9;33(4):634-648.e5. doi: 10.1016/j.ccell.2018.02.007.

PMID:
29551594
6.

Extending autologous transplantation as first line therapy in multiple myeloma patients with severe renal impairment: a retrospective study by the SFGM-TC.

Augeul-Meunier K, Chretien ML, Stoppa AM, Karlin L, Benboubker L, Diaz JMT, Mohty M, Yakoub-Agha I, Bay JO, Perrot A, Bulabois CE, Huynh A, Mercier M, Frenzel L, Avet-Loiseau H, de Latour RP, Cornillon J.

Bone Marrow Transplant. 2018 Jun;53(6):749-755. doi: 10.1038/s41409-018-0122-8. Epub 2018 Mar 9.

PMID:
29523884
7.

Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children.

Arama C, Diarra I, Kouriba B, Sirois F, Fedoryak O, Thera MA, Coulibaly D, Lyke KE, Plowe CV, Chrétien M, Doumbo OK, Mbikay M.

PLoS One. 2018 Feb 15;13(2):e0192850. doi: 10.1371/journal.pone.0192850. eCollection 2018.

8.

Mice Fed a High-Cholesterol Diet Supplemented with Quercetin-3-Glucoside Show Attenuated Hyperlipidemia and Hyperinsulinemia Associated with Differential Regulation of PCSK9 and LDLR in their Liver and Pancreas.

Mbikay M, Mayne J, Sirois F, Fedoryak O, Raymond A, Noad J, Chrétien M.

Mol Nutr Food Res. 2018 May;62(9):e1700729. doi: 10.1002/mnfr.201700729. Epub 2018 Apr 23.

PMID:
29396908
9.

Efficacy, safety, and cost of pomalidomide in relapsed and refractory multiple myeloma.

Gueneau P, Chretien ML, Cransac-Miet A, Aho LS, Lafon I, Favennec C, Guy J, Caillot D, Boulin M.

Eur J Haematol. 2018 May;100(5):518-525. doi: 10.1111/ejh.13039. Epub 2018 Mar 6.

PMID:
29393533
10.
11.

Expressed fusion gene landscape and its impact in multiple myeloma.

Cleynen A, Szalat R, Kemal Samur M, Robiou du Pont S, Buisson L, Boyle E, Chretien ML, Anderson K, Minvielle S, Moreau P, Attal M, Parmigiani G, Corre J, Munshi N, Avet-Loiseau H.

Nat Commun. 2017 Dec 1;8(1):1893. doi: 10.1038/s41467-017-00638-w.

12.

Antiviral activity of quercetin-3-β-O-D-glucoside against Zika virus infection.

Wong G, He S, Siragam V, Bi Y, Mbikay M, Chretien M, Qiu X.

Virol Sin. 2017 Dec;32(6):545-547. doi: 10.1007/s12250-017-4057-9.

PMID:
28884445
13.

Cognitive restructuring of gambling-related thoughts: A systematic review.

Chrétien M, Giroux I, Goulet A, Jacques C, Bouchard S.

Addict Behav. 2017 Dec;75:108-121. doi: 10.1016/j.addbeh.2017.07.001. Epub 2017 Jul 8. Review.

PMID:
28728039
14.

The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response.

Ooi TC, Krysa JA, Chaker S, Abujrad H, Mayne J, Henry K, Cousins M, Raymond A, Favreau C, Taljaard M, Chrétien M, Mbikay M, Proctor SD, Vine DF.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3452-3460. doi: 10.1210/jc.2017-00684.

PMID:
28673045
15.

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents.

Duchmann M, Braun T, Micol JB, Platzbecker U, Park S, Pilorge S, Beyne-Rauzy O, Vey N, Sébert M, Gruson B, Dumas PY, Guieze R, Chretien ML, Laribi K, Chait Y, Legros L, Sahnes L, Hirsch P, Salanoubat C, Solary E, Fenaux P, Itzykson R.

Blood Cancer J. 2017 May 12;7(5):e562. doi: 10.1038/bcj.2017.41. No abstract available.

16.

Using Virtual Reality in the Treatment of Gambling Disorder: The Development of a New Tool for Cognitive Behavior Therapy.

Bouchard S, Robillard G, Giroux I, Jacques C, Loranger C, St-Pierre M, Chrétien M, Goulet A.

Front Psychiatry. 2017 Feb 24;8:27. doi: 10.3389/fpsyt.2017.00027. eCollection 2017.

17.

Is It Time to Include CT "Reverse Halo Sign" and qPCR Targeting Mucorales in Serum to EORTC-MSG Criteria for the Diagnosis of Pulmonary Mucormycosis in Leukemia Patients?

Caillot D, Valot S, Lafon I, Basmaciyan L, Chretien ML, Sautour M, Million L, Legouge C, Payssot A, Dalle F.

Open Forum Infect Dis. 2016 Nov 8;3(4):ofw190. doi: 10.1093/ofid/ofw190. eCollection 2016 Oct. Erratum in: Open Forum Infect Dis. 2017 Jun 29;4(2):ofx025.

18.

Nosocomial Infections with IMP-19-Producing Pseudomonas aeruginosa Linked to Contaminated Sinks, France.

Amoureux L, Riedweg K, Chapuis A, Bador J, Siebor E, Péchinot A, Chrétien ML, de Curraize C, Neuwirth C.

Emerg Infect Dis. 2017 Feb;23(2):304-307. doi: 10.3201/eid2302.160649.

19.

Comparing expression and activity of PCSK9 in SPRET/EiJ and C57BL/6J mouse strains shows lack of correlation with plasma cholesterol.

Sirois F, Chrétien M, Mbikay M.

Mol Genet Metab Rep. 2016 Dec 10;10:11-17. eCollection 2017 Mar.

20.

Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study.

Garderet L, Beohou E, Caillot D, Stoppa AM, Touzeau C, Chretien ML, Karlin L, Moreau P, Fontan J, Blaise D, Polge E, Gueye MS, Ikhlef S, Marjanovic Z, Labopin M, Mohty M.

Haematologica. 2016 Nov;101(11):1390-1397. Epub 2016 Sep 9.

21.

Impact of pharmaceutical intervention on quality of life and coping strategies in patients with haematological malignancies.

Opsomer MA, Anota A, Noblot-Rossignol M, Bonnetain F, Pernot C, Chretien ML, Legouge C, Caillot D, Boulin M.

Ann Pharm Fr. 2016 Nov;74(6):439-447. doi: 10.1016/j.pharma.2016.03.007. Epub 2016 May 6.

PMID:
27162122
22.

H.E.S.S. Limits on Linelike Dark Matter Signatures in the 100 GeV to 2 TeV Energy Range Close to the Galactic Center.

Abdalla H, Abramowski A, Aharonian F, Ait Benkhali F, Akhperjanian AG, Andersson T, Angüner EO, Arrieta M, Aubert P, Backes M, Balzer A, Barnard M, Becherini Y, Becker Tjus J, Berge D, Bernhard S, Bernlöhr K, Birsin E, Blackwell R, Böttcher M, Boisson C, Bolmont J, Bordas P, Bregeon J, Brun F, Brun P, Bryan M, Bulik T, Capasso M, Carr J, Casanova S, Chakraborty N, Chalme-Calvet R, Chaves RC, Chen A, Chevalier J, Chrétien M, Colafrancesco S, Cologna G, Condon B, Conrad J, Couturier C, Cui Y, Davids ID, Degrange B, Deil C, Devin J, deWilt P, Djannati-Ataï A, Domainko W, Donath A, Drury LO, Dubus G, Dutson K, Dyks J, Dyrda M, Edwards T, Egberts K, Eger P, Ernenwein JP, Eschbach S, Farnier C, Fegan S, Fernandes MV, Fiasson A, Fontaine G, Förster A, Funk S, Füßling M, Gabici S, Gajdus M, Gallant YA, Garrigoux T, Giavitto G, Giebels B, Glicenstein JF, Gottschall D, Goyal A, Grondin MH, Grudzińska M, Hadasch D, Hahn J, Hawkes J, Heinzelmann G, Henri G, Hermann G, Hervet O, Hillert A, Hinton JA, Hofmann W, Hoischen C, Holler M, Horns D, Ivascenko A, Jacholkowska A, Jamrozy M, Janiak M, Jankowsky D, Jankowsky F, Jingo M, Jogler T, Jouvin L, Jung-Richardt I, Kastendieck MA, Katarzyński K, Katz U, Kerszberg D, Khélifi B, Kieffer M, King J, Klepser S, Klochkov D, Kluźniak W, Kolitzus D, Komin N, Kosack K, Krakau S, Kraus M, Krayzel F, Krüger PP, Laffon H, Lamanna G, Lau J, Lees JP, Lefaucheur J, Lefranc V, Lemière A, Lemoine-Goumard M, Lenain JP, Leser E, Liu R, Lohse T, Lorentz M, Lypova I, Marandon V, Marcowith A, Mariaud C, Marx R, Maurin G, Maxted N, Mayer M, Meintjes PJ, Meyer M, Mitchell AM, Moderski R, Mohamed M, Morå K, Moulin E, Murach T, de Naurois M, Niederwanger F, Niemiec J, Oakes L, O'Brien P, Odaka H, Ohm S, Ostrowski M, Öttl S, Oya I, Padovani M, Panter M, Parsons RD, Paz Arribas M, Pekeur NW, Pelletier G, Perennes C, Petrucci PO, Peyaud B, Pita S, Poon H, Prokhorov D, Prokoph H, Pühlhofer G, Punch M, Quirrenbach A, Raab S, Reimer A, Reimer O, Renaud M, de Los Reyes R, Rieger F, Romoli C, Rosier-Lees S, Rowell G, Rudak B, Rulten CB, Sahakian V, Salek D, Sanchez DA, Santangelo A, Sasaki M, Schlickeiser R, Schüssler F, Schulz A, Schwanke U, Schwemmer S, Settimo M, Seyffert AS, Shafi N, Shilon I, Simoni R, Sol H, Spanier F, Spengler G, Spies F, Stawarz Ł, Steenkamp R, Stegmann C, Stinzing F, Stycz K, Sushch I, Tavernet JP, Tavernier T, Taylor AM, Terrier R, Tibaldo L, Tluczykont M, Trichard C, Tuffs R, van der Walt J, van Eldik C, van Soelen B, Vasileiadis G, Veh J, Venter C, Viana A, Vincent P, Vink J, Voisin F, Völk HJ, Vuillaume T, Wadiasingh Z, Wagner SJ, Wagner P, Wagner RM, White R, Wierzcholska A, Willmann P, Wörnlein A, Wouters D, Yang R, Zabalza V, Zaborov D, Zacharias M, Zdziarski AA, Zech A, Zefi F, Ziegler A, Żywucka N; H.E.S.S. Collaboration.

Phys Rev Lett. 2016 Oct 7;117(15):151302. Epub 2016 Oct 7.

PMID:
27768338
23.

Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.

Dejoie T, Corre J, Caillon H, Hulin C, Perrot A, Caillot D, Boyle E, Chretien ML, Fontan J, Belhadj K, Brechignac S, Decaux O, Voillat L, Rodon P, Fitoussi O, Araujo C, Benboubker L, Fontan C, Tiab M, Godmer P, Luycx O, Allangba O, Pignon JM, Fuzibet JG, Legros L, Stoppa AM, Dib M, Pegourie B, Orsini-Piocelle F, Karlin L, Arnulf B, Roussel M, Garderet L, Mohty M, Meuleman N, Doyen C, Lenain P, Macro M, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H.

Blood. 2016 Dec 22;128(25):2941-2948. doi: 10.1182/blood-2016-07-726778. Epub 2016 Oct 11.

24.

Search for Dark Matter Annihilations towards the Inner Galactic Halo from 10 Years of Observations with H.E.S.S.

Abdallah H, Abramowski A, Aharonian F, Ait Benkhali F, Akhperjanian AG, Angüner E, Arrieta M, Aubert P, Backes M, Balzer A, Barnard M, Becherini Y, Becker Tjus J, Berge D, Bernhard S, Bernlöhr K, Birsin E, Blackwell R, Böttcher M, Boisson C, Bolmont J, Bordas P, Bregeon J, Brun F, Brun P, Bryan M, Bulik T, Capasso M, Carr J, Casanova S, Chakraborty N, Chalme-Calvet R, Chaves RC, Chen A, Chevalier J, Chrétien M, Colafrancesco S, Cologna G, Condon B, Conrad J, Couturier C, Cui Y, Davids ID, Degrange B, Deil C, deWilt P, Djannati-Ataï A, Domainko W, Donath A, Drury LO, Dubus G, Dutson K, Dyks J, Dyrda M, Edwards T, Egberts K, Eger P, Ernenwein JP, Eschbach S, Farnier C, Fegan S, Fernandes MV, Fiasson A, Fontaine G, Förster A, Funk S, Füßling M, Gabici S, Gajdus M, Gallant YA, Garrigoux T, Giavitto G, Giebels B, Glicenstein JF, Gottschall D, Goyal A, Grondin MH, Grudzińska M, Hadasch D, Hahn J, Hawkes J, Heinzelmann G, Henri G, Hermann G, Hervet O, Hillert A, Hinton JA, Hofmann W, Hoischen C, Holler M, Horns D, Ivascenko A, Jacholkowska A, Jamrozy M, Janiak M, Jankowsky D, Jankowsky F, Jingo M, Jogler T, Jouvin L, Jung-Richardt I, Kastendieck MA, Katarzyński K, Katz U, Kerszberg D, Khélifi B, Kieffer M, King J, Klepser S, Klochkov D, Kluźniak W, Kolitzus D, Komin N, Kosack K, Krakau S, Kraus M, Krayzel F, Krüger PP, Laffon H, Lamanna G, Lau J, Lees JP, Lefaucheur J, Lefranc V, Lemière A, Lemoine-Goumard M, Lenain JP, Leser E, Lohse T, Lorentz M, Lui R, Lypova I, Marandon V, Marcowith A, Mariaud C, Marx R, Maurin G, Maxted N, Mayer M, Meintjes PJ, Menzler U, Meyer M, Mitchell AM, Moderski R, Mohamed M, Morå K, Moulin E, Murach T, de Naurois M, Niederwanger F, Niemiec J, Oakes L, Odaka H, Ohm S, Öttl S, Ostrowski M, Oya I, Padovani M, Panter M, Parsons RD, Paz Arribas M, Pekeur NW, Pelletier G, Petrucci PO, Peyaud B, Pita S, Poon H, Prokhorov D, Prokoph H, Pühlhofer G, Punch M, Quirrenbach A, Raab S, Reimer A, Reimer O, Renaud M, de Los Reyes R, Rieger F, Romoli C, Rosier-Lees S, Rowell G, Rudak B, Rulten CB, Sahakian V, Salek D, Sanchez DA, Santangelo A, Sasaki M, Schlickeiser R, Schüssler F, Schulz A, Schwanke U, Schwemmer S, Seyffert AS, Shafi N, Simoni R, Sol H, Spanier F, Spengler G, Spieß F, Stawarz L, Steenkamp R, Stegmann C, Stinzing F, Stycz K, Sushch I, Tavernet JP, Tavernier T, Taylor AM, Terrier R, Tluczykont M, Trichard C, Tuffs R, van der Walt J, van Eldik C, van Soelen B, Vasileiadis G, Veh J, Venter C, Viana A, Vincent P, Vink J, Voisin F, Völk HJ, Vuillaume T, Wadiasingh Z, Wagner SJ, Wagner P, Wagner RM, White R, Wierzcholska A, Willmann P, Wörnlein A, Wouters D, Yang R, Zabalza V, Zaborov D, Zacharias M, Zdziarski AA, Zech A, Zefi F, Ziegler A, Żywucka N; H.E.S.S. Collaboration.

Phys Rev Lett. 2016 Sep 9;117(11):111301. doi: 10.1103/PhysRevLett.117.111301. Epub 2016 Sep 8.

PMID:
27661677
25.

CD45 phosphatase is crucial for human and murine acute myeloid leukemia maintenance through its localization in lipid rafts.

Saint-Paul L, Nguyen CH, Buffière A, Pais de Barros JP, Hammann A, Landras-Guetta C, Filomenko R, Chrétien ML, Johnson P, Bastie JN, Delva L, Quéré R.

Oncotarget. 2016 Oct 4;7(40):64785-64797. doi: 10.18632/oncotarget.11622.

26.

Outbreak of Extended-Spectrum Beta-Lactamase Producing Enterobacter cloacae with High MICs of Quaternary Ammonium Compounds in a Hematology Ward Associated with Contaminated Sinks.

Chapuis A, Amoureux L, Bador J, Gavalas A, Siebor E, Chrétien ML, Caillot D, Janin M, de Curraize C, Neuwirth C.

Front Microbiol. 2016 Jul 12;7:1070. doi: 10.3389/fmicb.2016.01070. eCollection 2016.

27.

Prophylactic Efficacy of Quercetin 3-β-O-d-Glucoside against Ebola Virus Infection.

Qiu X, Kroeker A, He S, Kozak R, Audet J, Mbikay M, Chrétien M.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5182-8. doi: 10.1128/AAC.00307-16. Print 2016 Sep.

28.

Trim33/Tif1γ is involved in late stages of granulomonopoiesis in mice.

Chrétien ML, Legouge C, Martin RZ, Hammann A, Trad M, Aucagne R, Largeot A, Bastie JN, Delva L, Quéré R.

Exp Hematol. 2016 Aug;44(8):727-739.e6. doi: 10.1016/j.exphem.2016.04.009. Epub 2016 Apr 27.

PMID:
27130375
29.

Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.

Royer B, Minvielle S, Diouf M, Roussel M, Karlin L, Hulin C, Arnulf B, Macro M, Cailleres S, Brion A, Brechignac S, Belhadj K, Chretien ML, Wetterwald M, Chaleteix C, Tiab M, Leleu X, Frenzel L, Garderet L, Choquet S, Fuzibet JG, Dauriac C, Forneker LM, Benboubker L, Facon T, Moreau P, Avet-Loiseau H, Marolleau JP.

J Clin Oncol. 2016 Jun 20;34(18):2125-32. doi: 10.1200/JCO.2015.63.1929. Epub 2016 Apr 25.

PMID:
27114594
30.

Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC).

Stamatoullas A, Brice P, Gueye MS, Mareschal S, Chevallier P, Bouabdallah R, Nguyenquoc S, Francois S, Turlure P, Ceballos P, Monjanel H, Bourhis JH, Guillerm G, Mohty M, Biron P, Cornillon J, Belhadj K, Bonmati C, Dilhuydy MS, Huynh A, Bernard M, Chrétien ML, Peffault de Latour R, Tilly H.

Bone Marrow Transplant. 2016 Jul;51(7):928-32. doi: 10.1038/bmt.2016.76. Epub 2016 Apr 4.

PMID:
27042842
31.

Evolution of procalcitonin, C-reactive protein and fibrinogen levels in neutropenic leukaemia patients with invasive pulmonary aspergillosis or mucormycosis.

Roques M, Chretien ML, Favennec C, Lafon I, Ferrant E, Legouge C, Plocque A, Golfier C, Duvillard L, Amoureux L, Bastie JN, Maurin-Bernier L, Dalle F, Caillot D.

Mycoses. 2016 Jun;59(6):383-90. doi: 10.1111/myc.12487. Epub 2016 Mar 2.

PMID:
26931315
32.

Emergency and elective pulmonary surgical resection in haematological patients with invasive fungal infections: a report of 50 cases in a single centre.

Chretien ML, Legouge C, Pagès PB, Lafon I, Ferrant E, Plocque A, Favennec C, Estivalet L, Bottolier-Lemallaz E, Dalle F, Bastie JN, Bernard A, Caillot D.

Clin Microbiol Infect. 2016 Sep;22(9):782-787. doi: 10.1016/j.cmi.2015.12.029. Epub 2016 Jan 22.

33.

60 YEARS OF POMC: From the prohormone theory to pro-opiomelanocortin and to proprotein convertases (PCSK1 to PCSK9).

Chrétien M, Mbikay M.

J Mol Endocrinol. 2016 May;56(4):T49-62. doi: 10.1530/JME-15-0261. Epub 2016 Jan 13. Review.

PMID:
26762158
34.

Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?

Chretien ML, Corre J, Lauwers-Cances V, Magrangeas F, Cleynen A, Yon E, Hulin C, Leleu X, Orsini-Piocelle F, Blade JS, Sohn C, Karlin L, Delbrel X, Hebraud B, Roussel M, Marit G, Garderet L, Mohty M, Rodon P, Voillat L, Royer B, Jaccard A, Belhadj K, Fontan J, Caillot D, Stoppa AM, Attal M, Facon T, Moreau P, Minvielle S, Avet-Loiseau H.

Blood. 2015 Dec 17;126(25):2713-9. doi: 10.1182/blood-2015-06-650242. Epub 2015 Oct 29.

35.

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association.

Debarri H, Lebon D, Roumier C, Cheok M, Marceau-Renaut A, Nibourel O, Geffroy S, Helevaut N, Rousselot P, Gruson B, Gardin C, Chretien ML, Sebda S, Figeac M, Berthon C, Quesnel B, Boissel N, Castaigne S, Dombret H, Renneville A, Preudhomme C.

Oncotarget. 2015 Dec 8;6(39):42345-53. doi: 10.18632/oncotarget.5645.

36.

The apoB-to-PCSK9 ratio: A new index for metabolic risk in humans.

Wassef H, Bissonnette S, Saint-Pierre N, Lamantia V, Cyr Y, Chrétien M, Faraj M.

J Clin Lipidol. 2015 Sep-Oct;9(5):664-75. doi: 10.1016/j.jacl.2015.06.012. Epub 2015 Jul 2.

PMID:
26350813
37.

β-Estradiol results in a proprotein convertase subtilisin/kexin type 9-dependent increase in low-density lipoprotein receptor levels in human hepatic HuH7 cells.

Starr AE, Lemieux V, Noad J, Moore JI, Dewpura T, Raymond A, Chrétien M, Figeys D, Mayne J.

FEBS J. 2015 Jul;282(14):2682-96. doi: 10.1111/febs.13309. Epub 2015 May 18.

38.

A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years.

Lang AS, Mounier M, Roques M, Chretien ML, Boulin M.

J Clin Pharm Ther. 2015 Aug;40(4):391-7. doi: 10.1111/jcpt.12273. Epub 2015 Apr 10.

PMID:
25865674
39.

Relationship between testosterone, estradiol and circulating PCSK9: Cross-sectional and interventional studies in humans.

Ooi TC, Raymond A, Cousins M, Favreau C, Taljaard M, Gavin C, Jolly EE, Malone S, Eapen L, Chretien M, Mbikay M, Mayne J.

Clin Chim Acta. 2015 Jun 15;446:97-104. doi: 10.1016/j.cca.2015.03.036. Epub 2015 Apr 7.

PMID:
25858546
40.

Constraints on an annihilation signal from a core of constant dark matter density around the milky way center with H.E.S.S.

Abramowski A, Aharonian F, Ait Benkhali F, Akhperjanian AG, Angüner EO, Backes M, Balenderan S, Balzer A, Barnacka A, Becherini Y, Becker Tjus J, Berge D, Bernhard S, Bernlöhr K, Birsin E, Biteau J, Böttcher M, Boisson C, Bolmont J, Bordas P, Bregeon J, Brun F, Brun P, Bryan M, Bulik T, Carrigan S, Casanova S, Chadwick PM, Chakraborty N, Chalme-Calvet R, Chaves RC, Chrétien M, Colafrancesco S, Cologna G, Conrad J, Couturier C, Cui Y, Davids ID, Degrange B, Deil C, deWilt P, Djannati-Ataï A, Domainko W, Donath A, Drury LO, Dubus G, Dutson K, Dyks J, Dyrda M, Edwards T, Egberts K, Eger P, Espigat P, Farnier C, Fegan S, Feinstein F, Fernandes MV, Fernandez D, Fiasson A, Fontaine G, Förster A, Füßling M, Gabici S, Gajdus M, Gallant YA, Garrigoux T, Giavitto G, Giebels B, Glicenstein JF, Gottschall D, Grondin MH, Grudzińska M, Hadasch D, Häffner S, Hahn J, Harris J, Heinzelmann G, Henri G, Hermann G, Hervet O, Hillert A, Hinton JA, Hofmann W, Hofverberg P, Holler M, Horns D, Ivascenko A, Jacholkowska A, Jahn C, Jamrozy M, Janiak M, Jankowsky F, Jung-Richardt I, Kastendieck MA, Katarzyński K, Katz U, Kaufmann S, Khélifi B, Kieffer M, Klepser S, Klochkov D, Kluźniak W, Kolitzus D, Komin N, Kosack K, Krakau S, Krayzel F, Krüger PP, Laffon H, Lamanna G, Lefaucheur J, Lefranc V, Lemière A, Lemoine-Goumard M, Lenain JP, Lohse T, Lopatin A, Lu CC, Marandon V, Marcowith A, Marx R, Maurin G, Maxted N, Mayer M, McComb TJ, Méhault J, Meintjes PJ, Menzler U, Meyer M, Mitchell AM, Moderski R, Mohamed M, Morå K, Moulin E, Murach T, de Naurois M, Niemiec J, Nolan SJ, Oakes L, Odaka H, Ohm S, Opitz B, Ostrowski M, Oya I, Panter M, Parsons RD, Paz Arribas M, Pekeur NW, Pelletier G, Petrucci PO, Peyaud B, Pita S, Poon H, Pühlhofer G, Punch M, Quirrenbach A, Raab S, Reichardt I, Reimer A, Reimer O, Renaud M, de Los Reyes R, Rieger F, Romoli C, Rosier-Lees S, Rowell G, Rudak B, Rulten CB, Sahakian V, Salek D, Sanchez DA, Santangelo A, Schlickeiser R, Schüssler F, Schulz A, Schwanke U, Schwarzburg S, Schwemmer S, Sol H, Spanier F, Spengler G, Spies F, Stawarz Ł, Steenkamp R, Stegmann C, Stinzing F, Stycz K, Sushch I, Tavernet JP, Tavernier T, Taylor AM, Terrier R, Tluczykont M, Trichard C, Valerius K, van Eldik C, van Soelen B, Vasileiadis G, Veh J, Venter C, Viana A, Vincent P, Vink J, Völk HJ, Volpe F, Vorster M, Vuillaume T, Wagner SJ, Wagner P, Wagner RM, Ward M, Weidinger M, Weitzel Q, White R, Wierzcholska A, Willmann P, Wörnlein A, Wouters D, Yang R, Zabalza V, Zaborov D, Zacharias M, Zdziarski AA, Zech A, Zechlin HS; (H.E.S.S. Collaboration).

Phys Rev Lett. 2015 Feb 27;114(8):081301. Epub 2015 Feb 24.

PMID:
25768750
41.

Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience.

Hebraud B, Magrangeas F, Cleynen A, Lauwers-Cances V, Chretien ML, Hulin C, Leleu X, Yon E, Marit G, Karlin L, Roussel M, Stoppa AM, Belhadj K, Voillat L, Garderet L, Macro M, Caillot D, Mohty M, Facon T, Moreau P, Attal M, Munshi N, Corre J, Minvielle S, Avet-Loiseau H.

Blood. 2015 Mar 26;125(13):2095-100. doi: 10.1182/blood-2014-07-587964. Epub 2015 Jan 30.

42.

[Job satisfaction for fulfilled caregivers].

Michon F, Amiot C, Palvadeau C, Chrétien MC, Bécu AV.

Soins. 2014 Nov;(790):42-4. French.

PMID:
25619098
43.
44.

[A rare cause of pulmonary opacities: Lung localization of Waldenström's macroglobulinemia].

Monnet CM, Favrolt N, Bastie JN, Chrétien ML, Benoit F, Rossi C, Camus P, Bonniaud P.

Rev Mal Respir. 2014 Sep;31(7):632-5. doi: 10.1016/j.rmr.2013.10.648. Epub 2013 Dec 30. French.

PMID:
25239587
45.

Front-line transplantation program with lenalidomide, bortezomib, and dexamethasone combination as induction and consolidation followed by lenalidomide maintenance in patients with multiple myeloma: a phase II study by the Intergroupe Francophone du Myélome.

Roussel M, Lauwers-Cances V, Robillard N, Hulin C, Leleu X, Benboubker L, Marit G, Moreau P, Pegourie B, Caillot D, Fruchart C, Stoppa AM, Gentil C, Wuilleme S, Huynh A, Hebraud B, Corre J, Chretien ML, Facon T, Avet-Loiseau H, Attal M.

J Clin Oncol. 2014 Sep 1;32(25):2712-7. doi: 10.1200/JCO.2013.54.8164. Epub 2014 Jul 14.

PMID:
25024076
46.

Tif1γ regulates the TGF-β1 receptor and promotes physiological aging of hematopoietic stem cells.

Quéré R, Saint-Paul L, Carmignac V, Martin RZ, Chrétien ML, Largeot A, Hammann A, Pais de Barros JP, Bastie JN, Delva L.

Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10592-7. doi: 10.1073/pnas.1405546111. Epub 2014 Jul 7.

47.

Generic vancomycin products: Analysis of serum concentrations in patients with acute myeloid leukemia.

Monnier A, Malbranche C, Fagnoni P, Serge Aho L, Guerard P, Sgro C, Guignard MH, Croisier-Bertin D, Chavanet P, Chrétien ML, Caillot D, Boulin M.

Ann Pharm Fr. 2014 May;72(3):178-83. doi: 10.1016/j.pharma.2013.12.010. Epub 2014 Jan 21.

PMID:
24780833
48.

Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients.

Chretien ML, Hebraud B, Cances-Lauwers V, Hulin C, Marit G, Leleu X, Karlin L, Roussel M, Stoppa AM, Guilhot F, Lamy T, Garderet L, Pegourie B, Dib M, Sebban C, Lenain P, Brechignac S, Royer B, Wetterwald M, Legros L, Orsini-Piocelle F, Voillat L, Delbrel X, Caillot D, Macro M, Facon T, Attal M, Moreau P, Avet-Loiseau H, Corre J.

Haematologica. 2014 Jul;99(7):1236-8. doi: 10.3324/haematol.2013.098608. Epub 2014 Apr 11.

49.

Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation.

Fouquet G, Hebraud B, Garciaz S, Stoppa AM, Roussel M, Caillot D, Chrétien ML, Arnulf B, Szalat R, Garderet L, Benajiba L, Pegourie B, Regny C, Royer B, Caulier A, Touzeau C, Tessoulin B, Fermand JP, Facon T, Attal M, Loiseau HA, Moreau P, Leleu X.

J Cancer. 2014 Mar 11;5(3):248-52. doi: 10.7150/jca.8541. eCollection 2014.

50.

PCSK9: a key modulator of cardiovascular health.

Seidah NG, Awan Z, Chrétien M, Mbikay M.

Circ Res. 2014 Mar 14;114(6):1022-36. doi: 10.1161/CIRCRESAHA.114.301621. Review.

Supplemental Content

Loading ...
Support Center